The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...
GlobalData on MSN
FDA approves J&J’s TECNIS PureSee intraocular lens
The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
In response to this education gap, Eye Surgery Today was founded by nationally recognized key opinion leaders (KOLs) to make high-quality eye surgery education accessible to everyone.
FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results